Markets | |
Traders with successful investing and trading strategies require access to reliable and up-to-date information about markets. FinViz is an online stock screener that can be used in a variety of different ways. The screener enables traders to track the price movements of specific stocks and further... Read the Full Story |
|
From Our Partners | | BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one that gets burned with every transaction on what analysts are calling America's new financial grid.
The Nasdaq has received SEC approval to move stocks onto blockchain rails, and BlackRock CEO Larry Fink dedicated his entire 2026 annual letter to this infrastructure shift. Blockchain analyst Andy Howard is calling this asset 'Digital Oil' - and says institutional buyers are already positioned. | | Get the name, the ticker, and exactly how to buy it |
|
Markets | | Active value managers and value as a portfolio factor have underperformed the indexes since the global financial crisis. This lead to mass redemptions from top value managers like Greenlight and Pershing Square, and the proclamation of value’s death from financial pundits.
Investment strategi... Read the Full Story |
|
Markets | |
If you’re like most investors, you’ve spent a lot of time thinking about your retirement, and with good reason. According to the U.S. Census Bureau, the median household income is approximately $62,000. The average household income is only about $11,000 higher.
This means that the ave... Read the Full Story |
|
From Our Partners | | See the Signals Most Traders Miss
We monitor subtle shifts in order flow, volume patterns, and early trend behavior.
Stock News Trends highlights moves long before they hit mainstream screens. | | Join Free — Start Tracking Early Market Data |
|
Markets | | Trulieve is a vertically integrated cannabis producer, this means that they cultivate cannabis and also sell it in their own retail stores. The company calls this “seed-to-sale” integration. They’re primarily a server of the Florida medical marijuana market, with a sizable portion ... Read the Full Story |
|
Markets | | Quantitative investing is infinitely easier to implement on an individual level than it’s trading counterpart. It simply comes down to identifying factors that outperform and setting appropriate position balancing, risk management, and rebalancing criteria.
Investing quantitatively protects u... Read the Full Story |
|
From Our Partners | | With OpenAI and Anthropic moving closer to the IPO spotlight, AI excitement could spill into several public-market sectors this summer - and most investors may chase the obvious names too late.
A free report identifies 7 stocks positioned around themes that could matter most this summer: AI infrastructure, energy demand, travel, entertainment, home improvement, and more. Built for a market where leadership may rotate quickly. | | Download 7 Best Stocks to Own in Summer 2026 for free |
|
Markets | |
Stocks have been on a historic run. Recently, the Dow, Nasdaq, and S&P 500 all hit their all-time highs. But as you know, what comes up will eventually come down. And stocks have continued to exhibit volatility. As the calendar turns to October, it may be time for you to consider trading some ... Read the Full Story |
|
Markets | |
The Federal Reserve is holding its two-day meeting on September 17-18. At the conclusion of the meeting, the Fed is expected to announce a quarter-point interest rate cut (25 basis points). In advance of the decision, the markets are implying a 1.81% funds rate following the September meeting. Thi... Read the Full Story |
|
Markets | |
This is the first part of a three-part series about the basics of the options market. In this article, we’ll go over the basics of how options work, the parties involved, and some real-life examples.
An option is a contract between two parties that gives the holder the right, not the obliga... Read the Full Story |
|
Markets | | A contrarian investor goes against current market trends. He buys out of favor assets that are being slammed on CNBC every day. He shorts the market’s favorite growth stocks. He’s the cooky investor who has a portfolio that is long GameStop and short Square.
Their philosophy can be enca... Read the Full Story |
|
Markets | |
One of the dangers of the ongoing trade war between the United States and China is the opportunity cost that investors are paying by pulling money out of the market. Many institutional investors are decreasing their exposure to equities. Once Wall Street starts to pull their money out of the marke... Read the Full Story |
|
The Early Bird Stock Of The Day IGM Biosciences, Inc., a clinical-stage biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer and autoimmune and inflammatory diseases. It develops Aplitabart, a Death Receptor 5 Agonist IgM antibody for the treatment of colorectal cancer; imvotamab, a CD20 x CD3 bispecific IgM antibody to treat myositis, as well as for the treatment of systemic lupus erythematosus and rheumatoid arthritis that is Phase Ib clinical trial; and IGM-2644, a bispecific T cell engaging IgM antibody targeting CD38 and CD3 proteins for the treatment of autoimmune diseases. IGM Biosciences, Inc. has a collaboration and license agreement with Genzyme Corporation to generate, develop, manufacture, and commercialize IgM antibodies. The company was formerly known as Palingen, Inc. and changed its name to IGM Biosciences, Inc. in 2010. IGM Biosciences, Inc. was incorporated in 1993 and is headquartered in Mountain View, California. | | View Today's Stock Pick |
|
